Peripheral T-lymphocytes express WNT7A and its restoration in leukemia-derived lymphoblasts inhibits cell proliferation

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Ochoa Hernández, Alejandra B ^a,b   Ramos Solano, Moisés ^c   Meza Canales, Ivan D ^c   García Castro, Beatriz ^c   Rosales Reynoso, Mónica A ^c   Rosales Aviña, Judith A ^c   Barrera Chairez, Esperanza ^b   Ortíz Lazareno, Pablo C ^c   Hernández Flores, Georgina ^c   Bravo Cuellar, Alejandro ^c   Jave Suarez, Luis F ^c   Barros Núñez, Patricio ^a   Aguilar Lemarroy, Adriana ^a,c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

Author keywords

Anti proliferative; Leukemia; Non canonical pathway; Wnt signaling; WNT7A

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; RECOMBINANT PROTEIN; RNA; WNT7A PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; APOPTOSIS; ARTICLE; CD19+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LENTIVIRINAE; LEUKEMIA CELL LINE; LYMPHOBLAST; LYMPHOCYTE ACTIVATION; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA ISOLATION; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE; WNT7A GENE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD19; ANTIGENS, CD3; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; JURKAT CELLS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECOMBINANT PROTEINS; T-LYMPHOCYTES; WNT PROTEINS;

EID: 84858076616     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-60     Document Type: Article

References (51)

1. Chen X, Yang J, Evans PM, Liu C. Wnt signaling: the good and the bad. Acta Biochim Biophys Sin (Shanghai) 2008, 40:577-594.
2. Nusse R, Fuerer C, Ching W, Harnish K, Logan C, Zeng A, et al. Wnt signaling and stem cell control. Cold Spring Harb Symp Quant Biol 2008, 73:59-66. 10.1101/sqb.2008.73.035, 19028988.
3. Gordon MD, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 2006, 281:22429-22433. 10.1074/jbc.R600015200, 16793760.
4. Miller JR. The Wnts. Genome Biol 2002, 3:REVIEWS3001. 150458, 11806834.
5. van AR, Mikels A, Nusse R. Alternative wnt signaling is initiated by distinct receptors. Sci Signal 2008, 1:re9. 10.1126/scisignal.135re9, 18765832.
6. Willert K, Jones KA. Wnt signaling: is the party in the nucleus?. Genes Dev 2006, 20:1394-1404. 10.1101/gad.1424006, 16751178.
7. Fuerer C, Nusse R, ten BD. Wnt signalling in development and disease. Max Delbruck Center for Molecular Medicine meeting on Wnt signaling in Development and Disease. EMBO Rep 2008, 9:134-138. 10.1038/sj.embor.7401159, 2246409, 18188179.
8. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009, 17:9-26. 10.1016/j.devcel.2009.06.016, 2861485, 19619488.
9. Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005, 6:314-322. 10.1038/ni1164, 15665828.
10. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003, 423:409-414. 10.1038/nature01593, 12717450.
11. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810. 10.1146/annurev.cellbio.20.010403.113126, 15473860.
12. Groen RW, Oud ME, Schilder-Tol EJ, Overdijk MB. ten BD, Nusse R et a.: Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies. Cancer Res 2008, 68:6969-6977. 10.1158/0008-5472.CAN-08-1322, 18757411.
13. Pongracz JE, Stockley RA. Wnt signalling in lung development and diseases. Respir Res 2006, 7:15. 10.1186/1465-9921-7-15, 1397816, 16438732.
14. Majeti R, Becker MW, Tian Q, Lee TL, Yan X, Liu R, et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci USA 2009, 106:3396-3401. 10.1073/pnas.0900089106, 2642659, 19218430.
15. Valencia A, Roman-Gomez J, Cervera J, Such E, Barragan E, Bolufer P, et al. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia 2009, 23:1658-1666. 10.1038/leu.2009.86, 19387464.
16. Nygren MK, Dosen G, Hystad ME, Stubberud H, Funderud S, Rian E. Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines. Br J Haematol 2007, 136:400-413. 10.1111/j.1365-2141.2006.06442.x, 17156404.
17. Wu QL, Zierold C, Ranheim EA. Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia. Blood 2009, 113:3031-3039. 10.1182/blood-2008-06-163303, 2945928, 19179304.
18. Khan NI, Bendall LJ. Role of WNT signaling in normal and malignant hematopoiesis. Histol Histopathol 2006, 21:761-774.
19. Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM, et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004, 101:3118-3123. 10.1073/pnas.0308648100, 365753, 14973184.
20. Tickenbrock L, Hehn S, Sargin B, Choudhary C, Baumer N, Buerger H, et al. Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4. Int J Oncol 2008, 33:1215-1221.
21. Mai YJ, Qiu LG, Li ZJ, Yu Z, Li CH, Wang YF, et al. The expression of beta-catenin and its significance in leukemia cells. Zhonghua Xue Ye Xue Za Zhi 2007, 28:541-544.
22. Ge X, Wang X. Role of Wnt canonical pathway in hematological malignancies. J Hematol Oncol 2010, 3:33. 10.1186/1756-8722-3-33, 2954871, 20843302.
23. Sercan Z, Pehlivan M, Sercan HO. Expression profile of WNT, FZD and sFRP genes in human hematopoietic cells. Leuk Res 2010, 34:946-949. 10.1016/j.leukres.2010.02.009, 20206998.
24. Memarian A, Jeddi TM, Vossough P, Sharifian RA, Rabbani H, Shokri F. Expression profile of Wnt molecules in leukemic cells from Iranian patients with acute myeloblastic leukemia. Iran J Immunol 2007, 4:145-154.
25. Rao AS, Kremenevskaja N, Resch J, Brabant G. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. Eur J Endocrinol 2005, 153:929-938. 10.1530/eje.1.02038, 16322400.
26. Silva AK, Yi H, Hayes SH, Seigel GM, Hackam AS. Lithium chloride regulates the proliferation of stem-like cells in retinoblastoma cell lines: a potential role for the canonical Wnt signaling pathway. Mol Vis 2010, 16:36-45. 2805422, 20069066.
27. Weerkamp F, van Dongen JJ, Staal FJ. Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia. Leukemia 2006, 20:1197-1205. 10.1038/sj.leu.2404255, 16688226.
28. Martin V, Valencia A, Agirre X, Cervera J, Jose-Eneriz ES, Vilas-Zornoza A, et al. Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia. Cancer Sci 2010, 101:425-432. 10.1111/j.1349-7006.2009.01413.x, 19874313.
29. Memarian A, Hojjat-Farsangi M, Asgarian-Omran H, Younesi V, Jeddi-Tehrani M, Sharifian RA, et al. Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia. Leuk Lymphoma 2009, 50:2061-2070. 10.3109/10428190903331082, 19863181.
30. Roman-Gomez J, Cordeu L, Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, et al. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 2007, 109:3462-3469. 10.1182/blood-2006-09-047043, 17148581.
31. Johansson B, Billstrom R, Kristoffersson U, Akerman M, Garwicz S, Ahlgren T, et al. Deletion of chromosome arm 3p in hematologic malignancies. Leukemia 1997, 11:1207-1213. 10.1038/sj.leu.2400718, 9264371.
32. Bui TD, Lako M, Lejeune S, Curtis AR, Strachan T, Lindsay S, et al. Isolation of a full-length human WNT7A gene implicated in limb development and cell transformation, and mapping to chromosome 3p25. Gene 1997, 189:25-29. 10.1016/S0378-1119(96)00808-6, 9161407.
33. Ikegawa S, Kumano Y, Okui K, Fujiwara T, Takahashi E, Nakamura Y. Isolation, characterization and chromosomal assignment of the human WNT7A gene. Cytogenet Cell Genet 1996, 74:149-152. 10.1159/000134404, 8893824.
34. Lendeckel U, Scholz B, Arndt M, Frank K, Spiess A, Chen H, et al. Inhibition of alanyl-aminopeptidase suppresses the activation-dependent induction of glycogen synthase kinase-3beta (GSK-3beta) in human T cells. Biochem Biophys Res Commun 2000, 273:62-65. 10.1006/bbrc.2000.2883, 10873564.
35. Metcalfe C, Bienz M. Inhibition of GSK3 by Wnt signalling - two contrasting models. J Cell Sci 2011, 124:3537-3544. 10.1242/jcs.091991, 22083140.
36. Winn RA, Marek L, Han SY, Rodriguez K, Rodriguez N, Hammond M, et al. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. J Biol Chem 2005, 280:19625-19634. 10.1074/jbc.M409392200, 15705594.
37. Calvo R, West J, Franklin W, Erickson P, Bemis L, Li E, et al. Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci USA 2000, 97:12776-12781. 10.1073/pnas.97.23.12776, 18840, 11070089.
38. Ohira T, Gemmill RM, Ferguson K, Kusy S, Roche J, Brambilla E, et al. WNT7a induces E-cadherin in lung cancer cells. Proc Natl Acad Sci USA 2003, 100:10429-10434. 10.1073/pnas.1734137100, 193578, 12937339.
39. Tsui IF, Rosin MP, Zhang L, Ng RT, Lam WL. Multiple aberrations of chromosome 3p detected in oral premalignant lesions. Cancer Prev Res (Phila Pa) 2008, 1:424-429.
40. Chattopadhyay I, Singh A, Phukan R, Purkayastha J, Kataki A, Mahanta J, et al. Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutat Res 2010, 696:130-138.
41. Spinsanti P, De VT, Caruso A, Melchiorri D, Misasi R, Caricasole A, et al. Differential activation of the calcium/protein kinase C and the canonical beta-catenin pathway by Wnt1 and Wnt7a produces opposite effects on cell proliferation in PC12 cells. J Neurochem 2008, 104:1588-1598. 10.1111/j.1471-4159.2007.05111.x, 17988238.
42. Winn RA, Van SM, Hammond M, Rodriguez K, Crossno JT, Heasley LE, et al. Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma. J Biol Chem 2006, 281:26943-26950. 10.1074/jbc.M604145200, 16835228.
43. Tennis MA, Van Scoyk MM, Freeman SV, Vandervest KM, Nemenoff RA, Winn RA. Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer. Mol Cancer Res 2010, 8:833-843. 10.1158/1541-7786.MCR-09-0400, 2888899, 20501643.
44. Lindberg D, Akerstrom G, Westin G. Mutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic malignant pancreatic endocrine tumours. Clin Endocrinol (Oxf) 2007, 66:110-114.
45. Kirikoshi H, Katoh M. Expression of WNT7A in human normal tissues and cancer, and regulation of WNT7A and WNT7B in human cancer. Int J Oncol 2002, 21:895-900.
46. Caricasole A, Ferraro T, Iacovelli L, Barletta E, Caruso A, Melchiorri D, et al. Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins. J Biol Chem 2003, 278:37024-37031. 10.1074/jbc.M300191200, 12857724.
47. Carmon KS, Loose DS. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol Cancer Res 2008, 6:1017-1028. 10.1158/1541-7786.MCR-08-0039, 18567805.
48. Golan T, Yaniv A, Bafico A, Liu G, Gazit A. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. J Biol Chem 2004, 279:14879-14888. 10.1074/jbc.M306421200, 14747478.
49. Khan NI, Bradstock KF, Bendall LJ. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol 2007, 138:338-348. 10.1111/j.1365-2141.2007.06667.x, 17614820.
50. Siapati EK, Papadaki M, Kozaou Z, Rouka E, Michali E, Savvidou I, et al. Proliferation and bone marrow engraftment of AML blasts is dependent on beta-catenin signalling. Br J Haematol 2011, 152:164-174. 10.1111/j.1365-2141.2010.08471.x, 21118196.
51. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999, 96:1603-1608. 10.1073/pnas.96.4.1603, 15532, 9990071.